Grey Wolf Health Corp. (TSXV:WOLF)
Canada · Delayed Price · Currency is CAD 1.730
0.00 (0.00%)
Sep 9, 2026, 3:53 PM EST
Grey Wolf Health Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 37.65 | 35.76 | 26.83 | 25.41 | 22.64 | 13.1 | |
Revenue Growth | 21.33% | 33.30% | 5.58% | 12.26% | 72.85% | 70.47% |
Cost of Revenue | 17.47 | 16.7 | 13.07 | 12.58 | 11.07 | 5.95 |
Gross Profit | 20.18 | 19.06 | 13.76 | 12.83 | 11.56 | 7.15 |
Selling, General & Admin | 14.12 | 12.83 | 10.53 | 9.79 | 10.39 | 5.82 |
Operating Expenses | 16.04 | 14.82 | 11.73 | 11.17 | 11.85 | 7.01 |
Operating Income | 4.14 | 4.24 | 2.03 | 1.66 | -0.28 | 0.13 |
Interest Expense | -1.72 | -1.77 | -0.66 | -0.6 | -6.68 | -1.66 |
Interest & Investment Income | 0.11 | 0.11 | 0.2 | 0.15 | - | - |
Currency Exchange Gain (Loss) | -0.04 | -0.02 | -0.05 | -0.02 | -0.04 | 0.01 |
Other Non Operating Income (Expenses) | -0.18 | -0.18 | -0.12 | -0.09 | 8.75 | -0.31 |
EBT Excluding Unusual Items | 2.31 | 2.38 | 1.39 | 1.1 | 1.75 | -1.82 |
Other Unusual Items | - | - | - | - | - | -0.07 |
Pretax Income | 2.31 | 2.38 | 1.39 | 1.1 | 1.75 | -1.89 |
Income Tax Expense | 0.79 | 0.72 | 0.69 | 0.49 | -0.8 | -0.92 |
Net Income | 1.53 | 1.66 | 0.7 | 0.61 | 2.54 | -0.97 |
Net Income to Common | 1.53 | 1.66 | 0.7 | 0.61 | 2.54 | -0.97 |
Net Income Growth | 95.80% | 135.11% | 15.60% | -76.03% | - | - |
Shares Outstanding (Basic) | 34 | 34 | 31 | 31 | 17 | 14 |
Shares Outstanding (Diluted) | 34 | 34 | 31 | 31 | 17 | 14 |
Shares Change | 4.40% | 9.26% | 0.85% | 85.72% | 19.91% | 2.68% |
EPS (Basic) | 0.04 | 0.05 | 0.02 | 0.02 | 0.15 | -0.07 |
EPS (Diluted) | 0.04 | 0.05 | 0.02 | 0.02 | 0.15 | -0.07 |
EPS Growth | 87.54% | 142.28% | 1.81% | -87.09% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 4.42 | 3.31 | 1.21 | 2.15 | -0.76 | 2.12 |
Free Cash Flow Per Share | 0.13 | 0.10 | 0.04 | 0.07 | -0.05 | 0.15 |
Gross Margin | 53.61% | 53.30% | 51.28% | 50.48% | 51.09% | 54.59% |
Operating Margin | 11.00% | 11.85% | 7.56% | 6.53% | -1.24% | 1.03% |
Profit Margin | 4.05% | 4.63% | 2.63% | 2.40% | 11.24% | -7.40% |
Free Cash Flow Margin | 11.75% | 9.26% | 4.52% | 8.46% | -3.38% | 16.22% |
EBITDA | 6.53 | 6.73 | 3.46 | 2.92 | 1.09 | 1.14 |
EBITDA Margin | 17.34% | 18.83% | 12.90% | 11.48% | 4.80% | 8.67% |
D&A For EBITDA | 2.39 | 2.49 | 1.43 | 1.26 | 1.37 | 1 |
EBIT | 4.14 | 4.24 | 2.03 | 1.66 | -0.28 | 0.13 |
EBIT Margin | 11.00% | 11.85% | 7.56% | 6.53% | -1.24% | 1.03% |
Effective Tax Rate | 34.02% | 30.31% | 49.37% | 44.50% | - | - |
Advertising Expenses | - | 0.41 | 0.42 | 0.44 | 0.63 | 0.29 |